Trial Details
COMPLETEDBasic Information
| Clinical ID | c1446 |
|---|---|
| Identifier | NCT05029921 |
| Trial Title | A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Ustekinumab |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Beijing |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2021-12-10 |
|---|---|
| Primary Completion Date | 2025-05-18 |
| Completion Date | 2025-05-18 |